# To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension

> **NCT06343298** · PHASE2 · RECRUITING · sponsor: **E-Star BioTech, LLC** · enrollment: 120 (estimated)

## Conditions studied

- Difficult to Control Hypertension

## Interventions

- **DRUG:** MANP
- **OTHER:** Placebo Matched control

## Key facts

- **NCT ID:** NCT06343298
- **Lead sponsor:** E-Star BioTech, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-17
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-10-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06343298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06343298, "To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06343298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*